Introduction to mycoplasma and cell product risks

Mycoplasma species are the most common contaminants in cellular therapies. This webinar introduces mycoplasmas and outlines the risks they present and the remediation strategies required to control the microorganisms.

Topic areas we cover include:

• Risks posed to cellular products
• Sterile filtration challenges
• Surface adherence challenges
• Sources of contamination including association with cell culture reagents
• Remediation strategies, including donor material assessment
• Regulations

Dr. Tim Sandle has over twenty-five years’ experience of microbiological research and biopharmaceutical processing. He is a member of several editorial boards and he has written over six hundred book chapters, peer reviewed papers and technical articles relating to microbiology. Dr. Sandle works for a pharmaceutical manufacturer in the UK, and is a visiting tutor at both the University of Manchester and UCL.